triple negative breast cancer; (ER-, PR-, HER2-)

From Aaushi
Jump to navigation Jump to search

Epidemiology

  • black women twice as likely as white women to be diagnosed with triple-negative breast cancer[3]
  • they are also more likely to die from the disease[3]

Pathology

Management

More general terms

References

  1. 1.0 1.1 1.2 1.3 Medical Knowledge Self Assessment Program (MKSAP) 17, 18. American College of Physicians, Philadelphia 2015, 18.
  2. 2.0 2.1 FDA Approval Notice. March 8, 2019 FDA approves atezolizumab for PD-L1 positive unresectable locally advanced or metastatic triple-negative breast cancer. https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm633065.htm
  3. 3.0 3.1 3.2 3.3 3.4 Winn S UC Davis researchers help decode the cause of aggressive breast cancer in women of color. Cancer Care. December 20, 2024 https://health.ucdavis.edu/news/headlines/uc-davis-researchers-help-decode-the-cause-of-aggressive-breast-cancer-in-women-of-color/2024/12